Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
compounded under Section 503A pharmacy rules Typical research dose / 250-500 mcg subcutaneous injection once daily Lethal dose in humans / none reported in published literature as of May 2026 GH-receptor activation / absent at standard and supra-pharmacologic doses per Heffernan et al
NNMT inhibition supports improved metabolism and energy balance
Avoid taking it close to bedtime as NAD elevation may impact circadian signaling
5-Amino-1MQs ability to shift the bodys energy utilization from storage to active fat-burning helps prevent the buildup of harmful fat, reducing these effects
[1] This medication is available through both 503A compounding pharmacies and 503B outsourcing facilities, meaning it can be prepared for individual prescriptions or in bulk for office use
US$ 28.95
US$ 21.77
US$ 29.93
US$ 29.55
US$ 20.54
